We welcome you at the EuroMedLab 2025!
Meet the team and discover the full product portfolio for all your calprotectin needs at Euromedlab 2025, taking place from May 19th–22nd in Brussels. Visit us at Booth #226. From patient to lab, BÜHLMANN Laboratories supports you every step of the way.
BÜHLMANN Highlights at EuroMedLab 2025
Calprotectin Portfolio
BÜHLMANN has launched its first assay for fecal calprotectin testing almost 20 years ago and is today considered the gold-standard for IBD diagnosis and monitoring.
Our range of assays covers all customers’ needs, from the patients’ home to high-throughput laboratories.
Grow your lab confidently with our trusted portfolio. BÜHLMANN calprotectin assay guarantees the same standardization across all test platforms we offer.
We cover the broadest product range in the market offering from the FDA cleared market leader BÜHLMANN fCAL® ELISA, to the Quantum Blue® rapid test, the home test IBDoc® and to the automated, random-access BÜHLMANN fCAL® turbo, a solution for every need. The BÜHLMANN calprotectin assays appear in more than 100 peer reviewed clinical publications thereby demonstrating our tests’ reliability and highest quality.
BÜHLMANN Laboratories is not only leader in unique diagnostic assays for calprotectin but has also the most innovative stool preparation device demonstrating the importance of pre-analytics in calprotectin measurement. The CALEX® Cap, CALEX® Cap Collection Set and CALEX® Valve offer simple and hygienic stool collection and all variants are pre-filled with the BÜHLMANN extraction buffer, that guarantees unique stability of the analyte at Room Temperature.
Visit our website here to get to know more!
CALEX® Cap – from home to the lab, with you every step of the way
The CALEX® Cap stool extraction device is an efficient, convenient and hygienic tool for extraction of stool samples uniquely stable even at room temperature and is fully compatible with total laboratory automation (TLA) solutions for maximum workflow optimization.
You are currently viewing a placeholder content from Youtube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
Check out our presentations and video program at our booth!
Visit our booth and get to know our specialists in a round of products presentations. Sit down and relax getting to know our portfolio assisting to a curated selection of videos.
BÜHLMANN Poster
to be exhibited at EuroMedLab 2025
We are pleased to share our poster presented this year:
P0719: First insights into the analytical performance and stability assessment of the Quantum Blue® fPELA assay
BÜHLMANN Products
BÜHLMANN Calprotectin Assays – From niche to full automation
The combination of the test with the CALEX® Cap extraction device or the fecal home extraction kit CALEX® Cap Collection Set strongly simplifies the cumbersome procedure for stool pre-analytics and is adapted to be applied on clinical chemistry analyzers. The product portfolio includes the FDA cleared BÜHLMANN fCAL® turbo for high throughput testing. The immuno turbidimetric fecal calprotectin assay BÜHLMANN fCAL® turbo provides flexible and random access applications on all major clinical chemistry platforms. The assay allows short turnaround time from fecal sample to the reportable result. BÜHLMANN also offers the FDA cleared market leader BÜHLMANN fCAL® ELISA and the Quantum Blue® calprotectin rapid tests. Further to that, the portfolio includes IBDoc®, a highly successful IBD home test for patients using an app that transforms smartphones into a calprotectin test reading device.
The new assay BÜHLMANN fPELA® turbo and the well-established BÜHLMANN fCAL® turbo together with the CALEX® Cap have revolutionized fecal testing. Both turbidimetric immunoassays can be easily applied to a wide range of clinical chemistry analyzers, providing Total Laboratory Automation ( with fast turn-around-time (TAT) and immensely improve laboratory workflow. The combined use of these products makes reliable results possible also for high concentrations that demand for an extended measuring range.
BÜHLMANN CALEX® Cap preparation device offers efficient, convenient, and hygienic stool collection and extraction. Its simple design and buffer offer the user high safety as well as high stability of stool samples extracts even at room temperature. Furthermore, the CALEX® Cap is designed to be fully compatible with Total Lab Automation solutions and provide the best lab workflow management.
The CALEX® Cap Collection Set places this device to patients home, further reducing the laboratory task of stool preparation procedure for fecal calprotectin and pancreatic elastase testing with BÜHLMANN assays. The CALEX® Cap preparation device offers efficient, convenient, and hygienic direct home stool collection.
The BÜHLMANN sCAL® turbo assay is a powerful tool to be applied on most clinical chemistry analyzers for measurement of serum calprotectin. The turbidimetric technology allows rapid and flexible random-access offering high throughput options in the routine laboratory. Serum calprotectin is a new biomarker for inflammatory disorders with significantly increased specificity than current acute-phase reactants like CRP and ESR. Recent clinical data shows that BÜHLMANN sCAL® turbo can also be successfully used in clinical practice for the differential diagnosis of systemic juvenile idiopathic arthritis.
The BÜHLMANN Quantum Blue® rapid test combines the simplicity and speed of lateral flow technology with quantitative measurement capabilities through a small reading device. The Quantum Blue® Reader provides a quantitative value within minutes and is therefore an ideal tool in a small lab setting that needs immediate results. The BÜHLMANN product line offers a fecal calprotectin test suitable for IBD diagnosis and therapy follow-up of IBD patients. Besides calprotectin assay, the Quantum Blue® portfolio includes therapeutic monitoring of anti-TNFα biologics, including trough level assessment and anti-therapeutic antibody determination.
IBDoc® is the first in vitro diagnostic home testing device measuring the inflammatory marker fecal calprotectin at home. The IBDoc® app turns a smartphone into a test cassette reader using state of the art image processing. Stool extraction is performed using the CALEX® Valve that is characterized by its simple and convenient handling and extraction of stool samples by patients. The secure data connection between the IBDoc® app and the IBDoc® Portal allows Health Care Professionals to real time monitoring of patient results. The IBDoc® Portal also includes an application programming interface (API) that directly transfers test results into electronic patient records (EHR) or laboratory information systems (LIMS) via a common web standard or HL7 based interface.
BÜHLMANN launched its first assay for fecal calprotectin testing almost 20 years ago and is today considered the gold standard based on the the the BÜHLMANN fCAL® ELISA with wide measuring capabilities, both for diagnosis and monitoring of inflammatory bowel disease.